Aimmune Therapeutics, Inc

(NASDAQ:AIMT)

Latest On Aimmune Therapeutics, Inc (AIMT):

Date/Time Type Description Signal Details
2020-11-01 16:54 ESTFinancialsCompany financials have been released.Neutral
2020-10-15 19:30 ESTInsider Tradedes Produits Nestle S.A. Societe has indirectly acquired of 10,681,704 shares.Buy
2020-10-15 19:30 ESTInsider Tradedes Produits Nestle S.A. Societe has indirectly acquired of 43,435,583 shares.Buy
2020-10-15 08:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $33.32 to $31.28.Sell
2020-10-14 16:31 ESTInsider TradeKATHRYN E FALBERG has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:31 ESTInsider TradeDANIEL C MD ADELMAN has directly disposed of 22,343 shares and currently holds 0 shares.Sell
2020-10-14 16:31 ESTInsider TradeMark T Iwicki has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:31 ESTInsider TradePATRICK G ENRIGHT has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:31 ESTInsider TradeERIC BJERKHOLT has directly disposed of 23,905 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeStacey Denenberg Seltzer has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeBRETT K HAUMANN has directly disposed of 13,313 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeGregory Behar has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeMARK MCDADE has directly disposed of 7,840 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeJayson Donald Alexander Dallas has directly disposed of 89,250 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeDouglas T. Sheehy has directly disposed of 36,875 shares and currently holds 0 shares.Sell
2020-10-14 16:30 ESTInsider TradeAndrew Oxtoby has directly disposed of 20,250 shares and currently holds 0 shares.Sell
2020-10-14 05:41 ESTNewsNestle reports 84% holding in Aimmune TherapeuticsN/A
2020-10-05 22:00 ESTInsider TradeDANIEL C MD ADELMAN has directly acquired 34,932 shares and currently holds 63,807 shares.Buy
2020-10-05 21:15 ESTInsider TradeERIC BJERKHOLT has directly acquired 5,200 shares and currently holds 49,841 shares.Buy
2020-10-05 21:15 ESTInsider TradeDouglas T. Sheehy has directly acquired 30,888 shares and currently holds 85,426 shares.Buy
2020-09-26 04:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-21 13:34 ESTNewsNestle Acquiring Aimmune, And Other News: The Good, Bad And Ugly Of BiopharmaN/A
2020-09-21 13:33 ESTNewsAimmune Therapeutics: Do Not Tender Your Shares To NestleN/A
2020-09-14 08:03 ESTAnalyst RatingThe Analyst Target Price has increased from $32.77 to $33.32.Neutral
2020-09-14 03:31 ESTNewsNestle initiates tender offer for Aimmune TherapeuticsN/A
2020-09-10 17:29 ESTNewsAimmune Therapeutics: A Bargain For A Potential Blockbuster TherapyN/A
2020-09-01 12:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $35.18 to $32.77.Sell
2020-09-01 01:37 ESTNewsNestle to buy Aimmune Therapeutics for $2.6BN/A
2020-08-05 06:51 ESTNewsDBV Technologies down big on FDA rejection of Viaskin Peanut applicationN/A
2020-08-03 08:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $38.36 to $35.18.Neutral
2020-08-03 00:03 ESTFinancialsCompany financials have been released.Neutral
2020-08-02 00:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 16:50 ESTNewsAimmune Therapeutics EPS beats by $0.03N/A
2020-07-31 16:49 ESTNewsAimmune Therapeutics, Inc. (AIMT) CEO Jayson Dallas on Q2 2020 Results - Earnings Call TranscriptN/A
2020-07-31 00:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $38.73 to $38.36.Neutral
2020-07-30 15:09 ESTNewsAimmune Therapeutics Q2 Earnings PreviewN/A
2020-07-29 08:03 ESTAnalyst RatingThe Analyst Target Price has increased from $38.64 to $38.73.Buy
2020-07-28 15:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 00:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $38.82 to $38.64.Neutral
2020-07-23 16:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-20 08:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $39.2 to $38.82.Neutral
2020-06-09 08:03 ESTAnalyst RatingThe Analyst Target Price has increased from $36.89 to $39.2.Buy
2020-06-08 12:13 ESTNewsAimmune's Palforzia shows durable effect in studyN/A
2020-06-02 08:03 ESTEarnings EstimateAn EPS average of -$1.03 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 08:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $43.1 to $36.89.Neutral
2020-05-29 19:30 ESTInsider TradeStacey Denenberg Seltzer has directly acquired 7,840 shares and currently holds 18,061 shares.Buy
2020-05-29 19:30 ESTInsider TradeMARK MCDADE has directly acquired 7,840 shares and currently holds 34,692 shares.Buy
2020-05-29 19:30 ESTInsider TradePATRICK G ENRIGHT has directly disposed of 7,840 shares and currently holds 78,401 shares.Sell
2020-05-29 19:30 ESTInsider TradeKATHRYN E FALBERG has directly acquired 7,840 shares and currently holds 73,032 shares.Buy

About Aimmune Therapeutics, Inc (AIMT):

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead Characterized Oral Desensitization ImmunoTherapy (CODIT) product candidate is AR101, an investigational biologic, which is in Phase III clinical trial for the treatment of patients with peanut allergy. The company also engages in the research and development of AR201, a CODIT product candidate for the treatment of egg allergy in pediatric and young adult patients; and other CODIT product candidates targeting food allergies, such as cow's milk allergy. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. Aimmune Therapeutics, Inc. was founded in 2011 and is headquartered in Brisbane, California. As of October 9, 2020, Aimmune Therapeutics, Inc. operates as a subsidiary of Société des Produits Nestlé S.A.

See Advanced Chart

General

  • Name Aimmune Therapeutics, Inc
  • Symbol AIMT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 339
  • Fiscal Year EndDecember
  • IPO Date2015-08-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.aimmune.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3832.47
  • Price/Book (Most Recent Quarter) 12.55
  • Enterprise Value Revenue 3628.88
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Next Quarter EPS Estimate -$1.05
  • Operating Margin -49193%
  • Return on Assets -53%
  • Revenue 575000
  • Earnings Per Share -$3.73
  • Revenue Per Share $0.01
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 2.26 billion
  • EBITDA -227014000
  • PEG Ratio 0.16
  • Analyst Target Price $31.28
  • Book Value Per Share $2.75
View More

Share Statistics

  • Shares Outstanding 65.45 million
  • Shares Float 49.01 million
  • % Held by Insiders 2086%
  • % Held by Institutions 82.85%
  • Shares Short 4.18 million
  • Shares Short Prior Month 6.74 million
  • Short Ratio 0.99
  • Short % of Float 9%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 1.74
  • 52 Week High $37
  • 52 Week Low $10.09
  • 50 Day Moving Average 34.42
  • 200 Day Moving Average 20.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aimmune Therapeutics, Inc (AIMT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aimmune Therapeutics, Inc (AIMT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-06-302020-07-30$N/A-$1.06-$1.092.75%
2020-03-312020-05-11$575000-$1.34-$1.18-13.56%
2019-12-312020-02-27$N/A-$1.06-$1.060%
2019-09-302019-11-06$N/A-$1.03-$1.030%
2019-06-302019-08-08$N/A-$1.01-$0.94-7.45%
2019-03-312019-05-08$N/A-$0.87-$0.9710.31%
2018-12-312019-02-28$N/A-$0.95-$0.91-4.4%
2018-09-302018-11-08$N/A-$0.89-$0.901.11%
2018-06-302018-08-08$N/A-$0.91-$0.86-5.81%
2018-03-312018-05-08$N/A-$0.92-$0.71-29.58%
2017-12-312018-02-20$N/A-$0.81-$0.73-10.96%
2017-09-302017-11-06$N/A-$0.63-$0.7212.5%
2017-06-302017-08-08$N/A-$0.65-$0.64-1.56%
2017-03-312017-05-08$N/A-$0.52-$0.567.14%
2016-12-312017-03-15$N/A-$0.55-$0.47-17.02%
2016-09-302016-11-14$N/A-$0.53-$0.46-15.22%
2016-06-302016-08-10$N/A-$0.43-$0.41-4.88%
2016-03-312016-05-16$N/A-$0.37-$0.407.5%
2015-12-312016-03-03$N/A-$0.39-$0.35-11.43%
2015-09-302015-11-04$N/A-$0.36-$0.23-56.52%
2015-06-302015-08-06$N/A-$1.60-$0.28-471.43%

Aimmune Therapeutics, Inc (AIMT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aimmune Therapeutics, Inc (AIMT) Chart:

Aimmune Therapeutics, Inc (AIMT) News:

Below you will find a list of latest news for Aimmune Therapeutics, Inc (AIMT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aimmune Therapeutics, Inc (AIMT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Aimmune Therapeutics, Inc (AIMT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320017779/0000899243-20-017779-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000008025519002707/0000080255-19-002707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000008025520001302/0000080255-20-001302-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000021545719003094/0000215457-19-003094-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000031506619000828/0000315066-19-000828-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000083423720004580/0000834237-20-004580-index.htm
2018-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318006569/0000899243-18-006569-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013923/0000899243-18-013923-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013924/0000899243-18-013924-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013926/0000899243-18-013926-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/0000899243-18-013930-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/0000899243-18-013931-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318013933/0000899243-18-013933-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm
2018-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318016599/0000899243-18-016599-index.htm
2018-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318017242/0000899243-18-017242-index.htm
2018-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318017243/0000899243-18-017243-index.htm
2018-11-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318028402/0000899243-18-028402-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm
2019-01-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319001868/0000899243-19-001868-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319001869/0000899243-19-001869-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319004861/0000899243-19-004861-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319004862/0000899243-19-004862-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319004863/0000899243-19-004863-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319004864/0000899243-19-004864-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319004866/0000899243-19-004866-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014962/0000899243-19-014962-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014964/0000899243-19-014964-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/0000899243-19-014965-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014969/0000899243-19-014969-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014970/0000899243-19-014970-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/0000899243-19-014971-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319023912/0000899243-19-023912-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319023984/0000899243-19-023984-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320004692/0000899243-20-004692-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320004693/0000899243-20-004693-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320004694/0000899243-20-004694-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320004697/0000899243-20-004697-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320004699/0000899243-20-004699-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320006843/0000899243-20-006843-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320006850/0000899243-20-006850-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320006851/0000899243-20-006851-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320006852/0000899243-20-006852-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320006853/0000899243-20-006853-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007093/0000899243-20-007093-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007096/0000899243-20-007096-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007098/0000899243-20-007098-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007103/0000899243-20-007103-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007110/0000899243-20-007110-index.htm
2020-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007111/0000899243-20-007111-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007813/0000899243-20-007813-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320007815/0000899243-20-007815-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320008140/0000899243-20-008140-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320008621/0000899243-20-008621-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm
2020-04-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320011293/0000899243-20-011293-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320012850/0000899243-20-012850-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320012853/0000899243-20-012853-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320012855/0000899243-20-012855-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320012859/0000899243-20-012859-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320012860/0000899243-20-012860-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/0000899243-20-014609-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014611/0000899243-20-014611-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014612/0000899243-20-014612-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014615/0000899243-20-014615-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014618/0000899243-20-014618-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/0000899243-20-014619-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320014621/0000899243-20-014621-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320017779/0000899243-20-017779-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320025342/0000899243-20-025342-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320025345/0000899243-20-025345-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320025348/0000899243-20-025348-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320025349/0000899243-20-025349-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320025350/0000899243-20-025350-index.htm
2020-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320026210/0000899243-20-026210-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320027457/0000899243-20-027457-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320027458/0000899243-20-027458-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320027460/0000899243-20-027460-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028171/0000899243-20-028171-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028172/0000899243-20-028172-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028173/0000899243-20-028173-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028174/0000899243-20-028174-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028176/0000899243-20-028176-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/0000899243-20-028177-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028178/0000899243-20-028178-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/0000899243-20-028179-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028180/0000899243-20-028180-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028181/0000899243-20-028181-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028182/0000899243-20-028182-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028183/0000899243-20-028183-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000093247119004464/0000932471-19-004464-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000110465920018693/0001104659-20-018693-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000110465920020466/0001104659-20-020466-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000114420419007017/0001144204-19-007017-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312518189409/0001193125-18-189409-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312518324626/0001193125-18-324626-index.htm
2018-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312518329424/0001193125-18-329424-index.htm
2018-11-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312518336579/0001193125-18-336579-index.htm
2018-12-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631650/000119312518340885/0001193125-18-340885-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519000571/0001193125-19-000571-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519002500/0001193125-19-002500-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519008957/0001193125-19-008957-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000119312519036136/0001193125-19-036136-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519077540/0001193125-19-077540-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519084341/0001193125-19-084341-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519146671/0001193125-19-146671-index.htm
2019-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519175698/0001193125-19-175698-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519245134/0001193125-19-245134-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519293433/0001193125-19-293433-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312519320879/0001193125-19-320879-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312520021708/0001193125-20-021708-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312520024920/0001193125-20-024920-index.htm
2020-02-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631650/000119312520030952/0001193125-20-030952-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520033257/0001193125-20-033257-index.htm
2020-04-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631650/000119312520119135/0001193125-20-119135-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312520235288/0001193125-20-235288-index.htm
2020-08-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631650/000119312520235338/0001193125-20-235338-index.htm
2020-08-31SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520235341/0001193125-20-235341-index.htm
2020-08-31SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520236371/0001193125-20-236371-index.htm
2020-09-14SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520244703/0001193125-20-244703-index.htm
2020-09-14SC 13E3Going private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520245300/0001193125-20-245300-index.htm
2020-09-14SC 14D9Solicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520245325/0001193125-20-245325-index.htm
2020-09-14SC 13E3Going private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520245328/0001193125-20-245328-index.htm
2020-09-21SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520249713/0001193125-20-249713-index.htm
2020-09-21SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520249724/0001193125-20-249724-index.htm
2020-09-21SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520249725/0001193125-20-249725-index.htm
2020-09-24SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520253505/0001193125-20-253505-index.htm
2020-09-29SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520257100/0001193125-20-257100-index.htm
2020-09-29SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520257119/0001193125-20-257119-index.htm
2020-09-29SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520257121/0001193125-20-257121-index.htm
2020-10-02SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520262502/0001193125-20-262502-index.htm
2020-10-05SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520263192/0001193125-20-263192-index.htm
2020-10-05SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520264012/0001193125-20-264012-index.htm
2020-10-05SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520264022/0001193125-20-264022-index.htm
2020-10-08SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520266415/0001193125-20-266415-index.htm
2020-10-13SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268115/0001193125-20-268115-index.htm
2020-10-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268119/0001193125-20-268119-index.htm
2020-10-13SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268136/0001193125-20-268136-index.htm
2020-10-13SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268141/0001193125-20-268141-index.htm
2020-10-13POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268640/0001193125-20-268640-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268641/0001193125-20-268641-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268643/0001193125-20-268643-index.htm
2020-10-13POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268644/0001193125-20-268644-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268646/0001193125-20-268646-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268648/0001193125-20-268648-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268649/0001193125-20-268649-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1631650/000119312520268654/0001193125-20-268654-index.htm
2020-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000119312520272122/0001193125-20-272122-index.htm
2020-10-2315-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1631650/000119312520275192/0001193125-20-275192-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631650/000130692320000004/0001306923-20-000004-index.htm
2020-10-1325-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1631650/000135445720000580/0001354457-20-000580-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018005311/0001564590-18-005311-index.htm
2018-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631650/000156459018007999/0001564590-18-007999-index.htm
2018-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1631650/000156459018008002/0001564590-18-008002-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018011815/0001564590-18-011815-index.htm
2018-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459018011827/0001564590-18-011827-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018014374/0001564590-18-014374-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018020500/0001564590-18-020500-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459018020513/0001564590-18-020513-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018027504/0001564590-18-027504-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459018028558/0001564590-18-028558-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459018028572/0001564590-18-028572-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459019005464/0001564590-19-005464-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631650/000156459019005514/0001564590-19-005514-index.htm
2019-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631650/000156459019005544/0001564590-19-005544-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631650/000156459019011278/0001564590-19-011278-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1631650/000156459019011280/0001564590-19-011280-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459019017185/0001564590-19-017185-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459019017202/0001564590-19-017202-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459019020915/0001564590-19-020915-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459019030768/0001564590-19-030768-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459019030786/0001564590-19-030786-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459019041020/0001564590-19-041020-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459019041059/0001564590-19-041059-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459020007372/0001564590-20-007372-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631650/000156459020007384/0001564590-20-007384-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631650/000156459020007397/0001564590-20-007397-index.htm
2020-04-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631650/000156459020016143/0001564590-20-016143-index.htm
2020-04-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1631650/000156459020016146/0001564590-20-016146-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459020024181/0001564590-20-024181-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459020024196/0001564590-20-024196-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459020027348/0001564590-20-027348-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631650/000156459020034776/0001564590-20-034776-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631650/000156459020034973/0001564590-20-034973-index.htm
2018-11-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000163165018000003/0001631650-18-000003-index.htm
2018-03-16DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1631650/000164892018000001/0001648920-18-000001-index.htm
2020-10-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631650/999999999520002834/9999999995-20-002834-index.htm
2020-10-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631650/999999999520002835/9999999995-20-002835-index.htm
2018-03-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631650/999999999718003873/9999999997-18-003873-index.htm
2018-08-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631650/999999999718007153/9999999997-18-007153-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631650/999999999718009615/9999999997-18-009615-index.htm
2019-03-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631650/999999999719001550/9999999997-19-001550-index.htm

Aimmune Therapeutics, Inc (AIMT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aimmune Therapeutics, Inc (AIMT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2086%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-13Andrew OxtobyChief Commercial OfficerSell20,250.0034.50698,625.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028183/0000899243-20-028183-index.htm
2020-10-13BRETT K HAUMANNDirectorSell13,313.0034.50459,298.500.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028178/0000899243-20-028178-index.htm
2020-10-13DANIEL C MD ADELMANChief Medical OfficerSell22,343.0034.50770,833.500.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028171/0000899243-20-028171-index.htm
2020-10-13Douglas T. SheehyOfficerSell36,875.0034.501,272,187.500.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028182/0000899243-20-028182-index.htm
2020-10-13ERIC BJERKHOLTChief Financial OfficerSell23,905.0034.50824,722.500.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028176/0000899243-20-028176-index.htm
2020-10-13Gregory BeharDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/0000899243-20-028179-index.htm
2020-10-13Jayson Donald Alexander DallasPresident and CEOSell89,250.0034.503,079,125.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028181/0000899243-20-028181-index.htm
2020-10-13KATHRYN E FALBERGDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028172/0000899243-20-028172-index.htm
2020-10-13MARK MCDADEDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028180/0000899243-20-028180-index.htm
2020-10-13Mark T IwickiDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028174/0000899243-20-028174-index.htm
2020-10-13PATRICK G ENRIGHTDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028173/0000899243-20-028173-index.htm
2020-10-13Stacey Denenberg SeltzerDirectorSell7,840.0034.50270,480.000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/0000899243-20-028177-index.htm
2019-05-23Gregory BeharDirectorBuy6,442.0010,192.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/0000899243-19-014971-index.htm
2019-05-23Stacey Denenberg SeltzerDirectorBuy6,442.0010,221.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/0000899243-19-014965-index.htm
2018-11-28Nestle Health Science US Holdings, Inc.10% Share HolderBuy3,237,529.0030.2798,000,002.8311,727,113.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm
2019-01-22Andrew OxtobyChief Commercial OfficerBuy12,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319001869/0000899243-19-001869-index.htm
2020-03-10Jayson Donald Alexander DallasPresident and CEOBuy2,665.0018.7449,934.11123,283.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320007815/0000899243-20-007815-index.htm
2020-02-28Jayson Donald Alexander DallasPresident and CEOBuy33,000.00123,699.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320006853/0000899243-20-006853-index.htm
2020-05-10Jayson Donald Alexander DallasPresident and CEOBuy3,300.00126,583.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320012860/0000899243-20-012860-index.htm
2020-02-07des Produits Nestle S.A. Societe10% Share HolderBuy1,000,000.0031.9731,970,000.0012,727,113.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm
2018-05-23KATHRYN E FALBERGDirectorBuy3,750.00128,644.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013924/0000899243-18-013924-index.htm
2019-02-22Mary M. RozenmanOfficerBuy7,500.0014,504.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319004862/0000899243-19-004862-index.htm
2020-05-27Gregory BeharDirectorBuy7,840.0018,032.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/0000899243-20-014619-index.htm
2020-05-27Stacey Denenberg SeltzerDirectorBuy7,840.0018,061.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/0000899243-20-014609-index.htm
2018-06-13ERIC BJERKHOLTChief Financial OfficerBuy1,600.0030.4148,663.0419,485.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318016599/0000899243-18-016599-index.htm
2020-05-27BRETT K HAUMANNDirectorBuy13,313.0019,563.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014618/0000899243-20-014618-index.htm
2018-05-23MARK MCDADEDirectorBuy3,750.0020,410.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013923/0000899243-18-013923-index.htm
2019-02-22DANIEL C MD ADELMANChief Medical OfficerBuy11,875.0021,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319004864/0000899243-19-004864-index.htm
2019-12-09DANIEL C MD ADELMANChief Medical OfficerSell20,000.0030.04600,716.0021,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm
2020-01-02DANIEL C MD ADELMANChief Medical OfficerSell20,000.0035.00700,038.0021,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm
2020-02-28Andrew OxtobyChief Commercial OfficerBuy11,250.0023,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320006850/0000899243-20-006850-index.htm
2020-10-13des Produits Nestle S.A. Societe10% Share HolderBuy10,681,704.0034.50368,518,788.0023,408,817.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm
2020-03-13Andrew OxtobyChief Commercial OfficerBuy3,000.0014.7644,265.9025,015.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320008621/0000899243-20-008621-index.htm
2018-05-23PATRICK G ENRIGHTDirectorBuy3,750.0026,619.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013933/0000899243-18-013933-index.htm
2019-05-23MARK MCDADEDirectorBuy6,442.0026,852.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014970/0000899243-19-014970-index.htm
2020-05-10Andrew OxtobyChief Commercial OfficerBuy2,420.0027,435.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320012853/0000899243-20-012853-index.htm
2020-02-28DANIEL C MD ADELMANChief Medical OfficerBuy8,750.0029,167.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320006851/0000899243-20-006851-index.htm
2020-05-10DANIEL C MD ADELMANChief Medical OfficerBuy2,420.0029,715.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320012850/0000899243-20-012850-index.htm
2018-06-01STEPHEN GEORGE DILLYOfficerSell2,498.0033.1982,898.63315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-04STEPHEN GEORGE DILLYOfficerSell2,612.0032.7485,519.49315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-05STEPHEN GEORGE DILLYOfficerSell38,825.0031.831,235,834.69315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-06STEPHEN GEORGE DILLYPresident and CEOSell30,465.0031.20950,370.91315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-07STEPHEN GEORGE DILLYPresident and CEOSell500.0031.5815,790.00315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-08STEPHEN GEORGE DILLYPresident and CEOSell42,106.0030.701,292,511.04315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-11STEPHEN GEORGE DILLYPresident and CEOSell29,457.0030.83908,300.70315,308.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm
2018-06-07STEPHEN GEORGE DILLYPresident and CEOSell32,098.0030.95993,320.76315,808.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-01STEPHEN GEORGE DILLYOfficerSell58,699.0032.591,913,094.33317,806.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-04STEPHEN GEORGE DILLYOfficerSell62,740.0031.841,997,836.09317,920.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2019-02-22ERIC BJERKHOLTChief Financial OfficerBuy13,125.0032,857.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319004863/0000899243-19-004863-index.htm
2019-05-23PATRICK G ENRIGHTDirectorBuy6,442.0033,061.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014964/0000899243-19-014964-index.htm
2018-05-22Douglas T. SheehyOfficerSell1,648.0033.0054,384.0033,079.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm
2018-05-23Mark T IwickiDirectorBuy3,750.0033,125.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013926/0000899243-18-013926-index.htm
2019-09-18ERIC BJERKHOLTChief Financial OfficerBuy1,550.0022.5734,976.6833,574.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319023984/0000899243-19-023984-index.htm
2018-06-11STEPHEN GEORGE DILLYPresident and CEOBuy29,457.003.0289,022.00344,765.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm
2018-06-06STEPHEN GEORGE DILLYPresident and CEOBuy30,465.003.0292,068.28345,773.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2020-05-27MARK MCDADEDirectorBuy7,840.0034,692.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014611/0000899243-20-014611-index.htm
2018-05-22Douglas T. SheehyOfficerBuy1,648.0012.9521,341.6034,727.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm
2018-06-07STEPHEN GEORGE DILLYPresident and CEOBuy32,598.003.0298,514.42347,906.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-06-05STEPHEN GEORGE DILLYOfficerBuy38,825.003.02117,333.03354,133.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-06-08STEPHEN GEORGE DILLYPresident and CEOBuy42,106.003.02127,248.54357,414.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm
2018-05-23Gregory BeharDirectorBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/0000899243-18-013930-index.htm
2018-06-01STEPHEN GEORGE DILLYOfficerBuy61,197.003.02184,943.45376,505.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2018-05-23Stacey Denenberg SeltzerDirectorBuy3,750.003,779.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/0000899243-18-013931-index.htm
2018-06-04STEPHEN GEORGE DILLYOfficerBuy65,352.003.02197,500.28380,660.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm
2019-05-23Mark T IwickiDirectorBuy6,442.0039,567.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014962/0000899243-19-014962-index.htm
2019-12-09DANIEL C MD ADELMANChief Medical OfficerBuy20,000.0011.45229,000.0041,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm
2020-01-02DANIEL C MD ADELMANChief Medical OfficerBuy20,000.0019.63392,600.0041,250.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm
2020-03-09ERIC BJERKHOLTChief Financial OfficerBuy1,000.0018.9718,970.0041,967.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320007813/0000899243-20-007813-index.htm
2020-02-28ERIC BJERKHOLTChief Financial OfficerBuy9,375.0042,949.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320006852/0000899243-20-006852-index.htm
2020-03-12ERIC BJERKHOLTChief Financial OfficerBuy1,000.0015.1015,100.0042,967.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320008140/0000899243-20-008140-index.htm
2020-10-13des Produits Nestle S.A. Societe10% Share HolderBuy43,435,583.0034.501,498,527,613.5043,435,583.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm
2020-05-10ERIC BJERKHOLTChief Financial OfficerBuy2,420.0045,387.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320012859/0000899243-20-012859-index.htm
2019-09-17PATRICK G ENRIGHTDirectorBuy12,500.0022.34279,216.2545,561.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319023912/0000899243-19-023912-index.htm
2019-02-22Douglas T. SheehyOfficerBuy12,500.0045,668.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319004866/0000899243-19-004866-index.htm
2019-12-26Douglas T. SheehyOfficerSell10,000.0033.03330,322.0045,668.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm
2020-01-16Douglas T. SheehyOfficerSell400.0037.0014,800.0045,668.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm
2020-01-16Douglas T. SheehyOfficerBuy400.0012.955,180.0046,068.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm
2020-05-27Mark T IwickiDirectorBuy7,840.0047,407.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014621/0000899243-20-014621-index.htm
2018-11-19Susan E. BarrowcliffeGeneral Manager, EuropeBuy40,000.003.02120,880.0049,375.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm
2020-10-05ERIC BJERKHOLTChief Financial OfficerBuy5,200.0019.44101,088.0049,841.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320027457/0000899243-20-027457-index.htm
2020-02-07des Produits Nestle S.A. Societe10% Share HolderBuy525,634.00319.68168,032,048.95525,634.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm
2020-03-17PATRICK G ENRIGHTDirectorBuy8,787.0011.50101,050.5054,348.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm
2020-05-10Douglas T. SheehyOfficerBuy2,420.0055,378.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320012855/0000899243-20-012855-index.htm
2019-12-26Douglas T. SheehyOfficerBuy10,000.0012.95129,500.0055,668.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm
2020-02-28Douglas T. SheehyOfficerBuy11,250.0056,918.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320006843/0000899243-20-006843-index.htm
2018-06-19Jayson Donald Alexander DallasPresident and CEOBuy60,000.0060,000.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318017243/0000899243-18-017243-index.htm
2020-03-17PATRICK G ENRIGHTDirectorBuy100,000.0011.401,139,650.006,113,134.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm
2018-11-19Jayson Donald Alexander DallasPresident and CEOBuy3,600.0027.5699,208.8063,600.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm
2018-11-19Jayson Donald Alexander DallasPresident and CEOBuy50.0027.561,378.0063,650.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm
2020-10-02DANIEL C MD ADELMANChief Medical OfficerBuy34,932.0011.45399,971.4063,807.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320027460/0000899243-20-027460-index.htm
2019-05-23KATHRYN E FALBERGDirectorBuy6,442.0065,192.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319014969/0000899243-19-014969-index.htm
2020-03-18PATRICK G ENRIGHTDirectorBuy16,213.0011.06179,344.9670,561.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm
2020-05-27KATHRYN E FALBERGDirectorBuy7,840.0073,032.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014615/0000899243-20-014615-index.htm
2020-05-27PATRICK G ENRIGHTDirectorSell7,840.0078,401.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320014612/0000899243-20-014612-index.htm
2018-02-26Nestle Health Science US Holdings, Inc.10% Share HolderBuy937,500.0032.0030,000,000.008,489,584.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm
2020-10-05Douglas T. SheehyOfficerBuy30,888.0012.95399,999.6085,426.00https://www.sec.gov/Archives/edgar/data/1631650/000089924320027458/0000899243-20-027458-index.htm
2018-03-04Susan E. BarrowcliffeGeneral Manager, EuropeBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318006569/0000899243-18-006569-index.htm
2018-11-19Susan E. BarrowcliffeGeneral Manager, EuropeSell40,000.0030.041,201,600.009,375.00https://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm
2019-02-22Jayson Donald Alexander DallasPresident and CEOBuy35,000.0098,650.00https://www.sec.gov/Archives/edgar/data/1631650/000089924319004861/0000899243-19-004861-index.htm